Literature DB >> 26237435

Regioselective Synthesis of V-Shaped Bistriazinyl-phenanthrolines.

Niall T Coogan1, Michael A Chimes1, James Raftery1, Pavle Mocilac1, Melissa A Denecke1.   

Abstract

A new, regioselective synthesis of V-shaped 2,9-bis(6-(4-halophenyl)-1,2,4-triazin-3-yl)-1,10-phenanthrolines (4XPhBTPhen) ligands was developed, creating access to a simple and reliable synthesis of precursors for future supramolecular actinide complexing systems. Described is a reactant-directed regioselective synthetic method, which was found to be high yielding and reliable and yields exclusively 6,6'-phenyl BTPhen derivatives (including 4-chloro and 4-bromo) in five simple steps. Molecular and crystal structures of PhBTP and PhBTPhen products are fully determined and both were found to be in space group C2/c. Additionally, molecular and crystal structures of Z and E isomers of 2-hydrazono-2-phenylacetaldehyde oxime, a reagent in the synthetic route, reveal existence of strong intramolecular N-H···O hydrogen bonding in the Z isomer explaining its lower solubility in water.

Entities:  

Year:  2015        PMID: 26237435     DOI: 10.1021/acs.joc.5b01380

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Pyridyldiimine macrocyclic ligands: Influences of template ion, linker length and imine substitution on ligand synthesis, structure and redox properties.

Authors:  Laura M Thierer; Qiuran Wang; Sam H Brooks; Peng Cui; Jia Qi; Michael R Gau; Brian C Manor; Patrick J Carroll; Neil C Tomson
Journal:  Polyhedron       Date:  2021-01-30       Impact factor: 3.052

2.  Exploring the Subtle Effect of Aliphatic Ring Size on Minor Actinide-Extraction Properties and Metal Ion Speciation in Bis-1,2,4-Triazine Ligands.

Authors:  Andrey V Zaytsev; Rachel Bulmer; Valery N Kozhevnikov; Mark Sims; Giuseppe Modolo; Andreas Wilden; Paul G Waddell; Andreas Geist; Petra J Panak; Patrik Wessling; Frank W Lewis
Journal:  Chemistry       Date:  2019-10-30       Impact factor: 5.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.